P39 immunoreactivity in glial cytoplasmic inclusions in brains with multiple system atrophy

Acta Neuropathologica

Volumn 101, Issue 3, 2001, Pages 190-194

  Honjyo, Y ^a   Kawamoto, Y ^a   Nakamura, S ^a   Nakano, S ^a   Akiguchi, I ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Cyclin dependent kinase 5; Glial cytoplasmic inclusions; Multiple system atrophy; Oligodendrocyte; P39

Indexed keywords

CYCLIN DEPENDENT KINASE 5; CYTOSKELETON PROTEIN; ENZYME ACTIVATOR; MICROTUBULE ASSOCIATED PROTEIN 2; NEUROFILAMENT PROTEIN; PROTEIN P39; TAU PROTEIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; AUTOPSY; BRAIN TISSUE; CELL INCLUSION; CELL LABELING; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVITY; FEMALE; GLIA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NERVE CELL; NERVE FIBER; OLIGODENDROGLIA; PERIKARYON; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SHY DRAGER SYNDROME;

EID: 0035104180     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010000246     Document Type: Article

References (26)

1. Argyrophilic glial intracytoplasmic inclusions in multiple system atrophy: Immunocytochemical and ultrastructural study
2. Immunohistochemical expression of microtuble-associated protein 5 (MAP5) in glial cells in multiple system atrophy
3. nck5ai mRNA) during rat brain development
4. Widespread alterations of alpha-synuclein in multiple system atrophy
5. Multiple system atrophy: A sporadic synucleinopathy
6. Consensus statement on the diagnosis of multiple system atrophy
7. Immunohistochemical localization of cdk5 activator p39 in the rat brain
8. Neuronal cdc-2 like kinase
9. cdc2
10. Immunocytochemical and ultrastructural studies of neuronal and oligodendroglial cytoplasmic inclusions in multiple system atrophy
11. nck5a and cyclin-dependent kinase 5 colocalize in Lewy bodies of brains with Parkinson's disease
12. Cyclin-dependent kinase 5 in Lewy body-like inclusions in anterior horn cells of a patient with sporadic amyotrophic lateral sclerosis
13. Cyclin-dependent kinase 5 and mitogen-activated protein kinase in glial cytoplasmic inclusions in multiple system atrophy
14. Expression of the endocytosis regulatory proteins Rab5 and Rabaptin-5 in glial cytoplasmic inclusions from brains with multiple system atrophy
15. Universal control mechanism regulating onset of M-phase
16. Accumulation of tubular structures in oligodedroglial and neuronal cells as the basic alteration in multiple system atrophy
17. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager symdrome)
18. Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments
19. Cyclin from sea urchins to Helas: Marking the human cell cycle
20. An isoform of the neuronal cyclin-dependent kinase 5 (cdk5) activator
21. p35 is a neuronal-specific regulatory subunit of cyclin-dependent kinase 5
22. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein
23. Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy
24. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediated its high-affinity, loop-specific binding to TAR RNA
25. Role of cyclins in neuronal differentiation of immortalized hippocampal cells
26. Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activator. p35 and p39, in the developing and adult rat central nervous system